Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
50 participants
OBSERVATIONAL
2024-09-16
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery
NCT05766891
Sex Hormones, Postoperative Pain and Opioid Use
NCT06023225
Postoperative Opt-In Narcotics Treatment in Breast
NCT05078398
Improving Surgical Patient Knowledge and Safe Use of Opioids
NCT03629314
Opioid Free Anesthesia in Breast Cancer Surgery
NCT04390698
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Opiophobia in Postsurgical Adults
Participants that agree to take part in this study, partiicpants will have a virtual visit, via Zoom, about 7 days after you are discharged from the hospital. The visit will take about 20 minutes, and you will meet with a member of the research team to complete several questionnaires.
13-item Barriers Questionnaire (BQ-13)
Given by questionnaire
Four-item Medication Adherence Questionnaire
Given by questionnaire
14-item Hospital Anxiety and Depression Scale (HADS)
Given by questionnaire
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
13-item Barriers Questionnaire (BQ-13)
Given by questionnaire
Four-item Medication Adherence Questionnaire
Given by questionnaire
14-item Hospital Anxiety and Depression Scale (HADS)
Given by questionnaire
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. inpatient surgical hospital stay lasting at least 23 hours
3. discharged home with a prescription for opioid analgesics
4. able to read, speak, and consent in English.
Exclusion Criteria
2. not discharged with a prescription for opioid analgesia to manage pain
3. individuals for whom there is documentation of inability to provide consent in the medical record.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sigma Theta Tau International
OTHER
M.D. Anderson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eileen Hacker, PHD,RN
Role: PRINCIPAL_INVESTIGATOR
M.D. Anderson Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Univerisity of Texas M. D. Anderson Cancer Center
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
MD Anderson Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2024-06535
Identifier Type: OTHER
Identifier Source: secondary_id
2024-0315
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.